Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profile of the Respimat soft mist inhaler for chronic obstructive pulmonary disease treatment: overview of its safety and efficacy.

Expert review of medical devices·2025
Same author

Does mixing inhaler devices lead to unchecked inhaler technique errors in patients with COPD? Findings from the cross-sectional observational MISMATCH study.

BMJ open respiratory research·2023
Same author

Impact of Treatable Traits on Asthma Control and Quality of Life.

The journal of allergy and clinical immunology. In practice·2023
Same author

Longitudinal Analysis of Quadriceps Muscle Strength in Patients with Previous COVID-19 Hospitalization and in Patients with Post-Acute Sequelae following Mild COVID-19.

Nutrients·2022
Same author

Patient activation is a treatable trait in patients with chronic airway diseases: An observational study.

Frontiers in psychology·2022
Same author

Persistent Exertional Dyspnea and Perceived Exercise Intolerance After Mild COVID-19: A Critical Role for Breathing Dysregulation?

Physical therapy·2022
Same journal

Safety and Pharmacokinetic Data for Inhaled Administration of Nintedanib Dry Powder Inhalation for Treatment of Pulmonary Fibrotic Diseases.

Journal of aerosol medicine and pulmonary drug delivery·2026
Same journal

Selecting the Optimal Inhaler in Asthma: Respiratory and Peripheral Muscle Strength as Predictors of DPI and MDI Response.

Journal of aerosol medicine and pulmonary drug delivery·2026
Same journal

Usability of Levodopa Cyclops<sup>®</sup> Compared to INBRIJA<sup>®</sup> During an off Episode in Parkinson's Disease Patients.

Journal of aerosol medicine and pulmonary drug delivery·2026
Same journal

Design of Dry Powder Inhalers: 1. Does Size Matter?

Journal of aerosol medicine and pulmonary drug delivery·2026
Same journal

Design of Dry Powder Inhalers: 2. The Impact of Suboptimal Peak Inspiratory Flow Rates on Bronchodilation in Patients with Obstructive Lung Diseases.

Journal of aerosol medicine and pulmonary drug delivery·2026
Same journal

Inhaler Adherence and Treatment Behaviors in COPD: A Study from Both Sides of the Aegean Sea.

Journal of aerosol medicine and pulmonary drug delivery·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

COPD Anno 2011: emphasis on bronch(iol)odilation.

Anke J M C Lahaije1, Yvonne F Heijdra, Laura M Willems

  • 1Radboud University Nijmegen Medical Centre, Department of Pulmonary Diseases, 454, Geert Grooteplein Zuid 8, 6500 HB Nijmegen, The Netherlands.

Journal of Aerosol Medicine and Pulmonary Drug Delivery
|June 13, 2012
PubMed
Summary
This summary is machine-generated.

Chronic obstructive pulmonary disease (COPD) significantly impacts daily life, leading to reduced physical activity. Bronchodilator therapy is crucial for managing COPD symptoms and improving patient outcomes.

More Related Videos

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Related Experiment Videos

Last Updated: May 21, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Area of Science:

  • Pulmonary Medicine
  • Respiratory Health

Background:

  • Chronic obstructive pulmonary disease (COPD) is a major global cause of disability and mortality.
  • Significant underdiagnosis and undertreatment of COPD exist, despite it being preventable and treatable.
  • Even mild COPD impairs health status, imposing burdens on patients and society.

Purpose of the Study:

  • To summarize current understanding of activity limitation causes and consequences in COPD.
  • To discuss the rationale for bronchodilator therapy in COPD management.
  • To highlight the role of pharmaceutical interventions in maintaining physical activity.

Main Methods:

  • Review of current literature on COPD.
  • Analysis of the relationship between physical activity and COPD progression.
  • Discussion of the impact of bronchodilation on COPD patients.

Main Results:

  • Activity limitation in COPD is progressive and linked to disease severity.
  • Reduced physical activity correlates with increased exacerbations, hospitalizations, and mortality.
  • Bronchodilation offers direct symptom relief and indirect benefits on exercise capacity and survival.

Conclusions:

  • Bronchodilator therapy is a cornerstone treatment for COPD.
  • Indirect effects of bronchodilators on physical activity and long-term outcomes are critical.
  • Maintaining physical activity is essential for managing COPD and improving quality of life.